Cardiac Output Monitoring Devices Market

Cardiac Output Monitoring Devices Market (Technology: Pulmonary Artery Catheter, Thermodilution Pulse Contour Analysis Technique, Lithium Dilution Technique, Arterial Waveform Analysis Techniques, Doppler, Transthoracic Impedance & Bioreactance Analysis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Cardiac Output Monitoring Devices Market Outlook 2031

  • The global cardiac output monitoring devices market was valued at US$ 1.14 Bn in 2021
  • The global market is projected to grow at a CAGR of 4.5% from 2022 to 2031
  • The global cardiac output monitoring devices market is anticipated to reach more than US$ 1.77 Bn by 2031

Analysts’ Viewpoint on Cardiac Output Monitoring Devices Market Scenario

Machine learning-based stroke volume estimation is creating incremental opportunities for companies in the cardiac output monitoring devices market. Companies should tap into opportunities in cardiac output measurement for maternal hemodynamic function. Emergence of non-invasive techniques has catalyzed the demand for cardiac output monitoring in pregnant women. Transthoracic impedance & bioreactance analysis is a key technology of the global cardiac output monitoring devices market; however, the technique is restricted for usage in certain medical procedures and is associated with inaccurate cardiac output estimations. Hence, manufacturers should increase their focus on Doppler echocardiography to enable healthcare companies to offer better outcomes in patients. Companies can increase efficacy in minimally invasive cardiac output monitor devices and increase availability of goal-directed treatment.

global cardiac output monitoring devices market

Cardiac Output Monitoring Devices Market Introduction

Cardiac output is the volume of blood pumped by the right or left ventricle of the heart per minute. It is dependent on heart rate and stroke volume. Methods of cardiac output monitoring are based on bioimpedance, pulse contour analysis, thermodilution, FloTrac monitoring, PiCCO cardiac output monitoring, Doppler, and Ficks principle. Usage of cardiac output monitoring devices is a significant aspect of evaluating patients in the critical care unit, operating theatre, and elsewhere. Technological advancements have enabled continuous real-time cardiac output (CO) monitoring using lithium dilution technique. This technique is expected to witness exponential growth in the cardiac output monitoring devices market during the forecast period. Lithium dilution (LiD) exhibits good correlation with the pulmonary artery catheter (PAC) thermodilution technique in hyperdynamic conditions. This trend has helped manufacturers in the cardiac output monitoring devices market to leverage opportunities in lithium dilution and PAC thermodilution techniques. Hence, LiDCOplus technology is being used as a reliable substitute for more invasive PAC thermodilution methods. Rise in trend of using minimally invasive cardiac output monitoring (MICOM) devices is driving the global cardiac output monitoring devices market size. Cardiac output monitoring devices analysis has led to innovations in less-invasive Doppler ultrasound.

The global cardiac output monitoring devices market is witnessing increase in adoption of less-invasive methods for measuring stroke volume (SV) and cardiac output in patients. Transthoracic electrical bioimpedance (TEB) and Doppler echocardiography (transthoracic echocardiography) are non-invasive methods used for the measurement of SV and CO. Invasive devices account for the largest share of the global cardiac output monitoring devices market in terms of revenue; however, large numbers of healthcare providers are opting for non-invasive methods to improve the quality of life of patients. The need for innovative methods to assess flow-based hemodynamic parameters such as SV in patients is rising. Healthcare providers in the cardiac output monitoring devices market landscape are increasing efforts to assess SV in patients, as it provides vital insights into systemic oxygen delivery and global tissue perfusion.

COVID-19 Impact on Cardiac Output Monitoring Devices Market

The COVID-19 pandemic has had a negative impact on the global cardiac output monitoring devices market. Governments of affected countries deferred non-essential surgeries and patient visits during the breakout year of the pandemic. This led to substantial decline in overall non-emergency surgery and treatments, thereby limiting the cardiac output monitoring devices market growth. Key market players reported decline in revenue due to the pandemic. However, the market has been recovering due to easing of restrictions by countries across the globe.

Technological Advancements Driving Transthoracic Impedance & Bioreactance Analysis Segment

In terms of technology, the transthoracic impedance & bioreactance analysis segment is projected to grow at the fastest CAGR during the forecast period. Transthoracic impedance & bioreactance measures the ‘phase shift’ of pulses of alternating current passed through the body using three electrodes. The bioreactance method estimates cardiac output by analyzing the frequency of relative phase shift of electronic current across the thorax. This approach results in improved precision of the bioreactance system as demonstrated by a 100-fold larger signal-to-noise ratio than that of bioimpedance, making it less susceptible to interference from adipose tissue, electrode placement, and excessive movement. Thoracic bioimpedance is a non-invasive method to measure cardiac output. Large numbers of validation studies are carried out using this technique. This is anticipated to drive the segment during the forecast period. Moreover, rise in trend of non-invasive continuous cardiac output measurement among healthcare professionals is anticipated to drive the segment in the next few years.

Increase in Prevalence of Cardiac Diseases Propelling Consumables & Accessories Segment

The consumables & accessories segment held the largest share of the global market in terms of revenue in 2021. The segment is anticipated to dominate the global market owing to the rise in prevalence of cardiac diseases and demand for consumables. End-users enter into rental agreements with manufacturers to install cardiac output monitoring devices at their facilities. According to the terms of the agreement, end-users need to purchase disposables to operate these devices. Hence, increase in installation base of cardiac output monitoring devices and rise in prevalence of cardiovascular diseases across the globe are likely to augment the usage of consumables during the forecast period.

Safety, Accuracy, and Reproducible Results Bolstering Invasive Segment

In terms of type, the invasive segment held significant share of the global market in 2021. Invasive cardiac output monitoring devices are ideal for continuous cardiac output monitoring, as these devices are safe, accurate, and provide reproducible results. Minimally invasive cardiac output monitoring devices provide real-time, beat-to-beat cardiac output, preload, and afterload. Increase in usage of minimally invasive technique with central venous lines and arterial lines is likely to drive the segment during the forecast period. Thus, high number of cardiac surgeries procedures performed annually, rise in demand for minimally invasive cardiac output monitoring, and development of non-invasive cardiac output monitoring devices are propelling the segment.

Rise in Investments in Advanced Medical Devices Driving Hospitals Segment

In terms of end-user, the hospitals segment held major share of the global market in 2021. Cardiac disorders are primarily treated in hospitals. Rise in number of hospitals and increase in patient preference to obtain treatment in hospitals are projected to propel the segment during the forecast period. The segment is likely to be driven by the increase in investments in hospitals for advanced medical devices. Government initiatives in developing health care infrastructure through public hospitals are also expected to drive the segment.

Regional Outlook of Global Cardiac Output Monitoring Devices Market

North America accounted for the largest share of the global cardiac output monitoring devices market in 2021. This can be ascribed to the increase in incidence of CVDs, rise in healthcare expenditure, surge in disposable income, growth in health awareness, and availability of technologically advanced devices in the region. According to the Population Reference Bureau, the geriatric population in the U.S. is projected to increase from 52 million in 2018 to 95 million by 2060. The geriatric population is likely to constitute 23% of the total population of the U.S. in 2060 as against 16% in 2018.

The market in Asia Pacific is likely to grow at the fastest CAGR from 2022 to 2031. Asia Pacific is witnessing gradual adoption of novel products, increase in health care expenditure, and changes in dynamics in the in vitro diagnostics industry. This is leading to a rise in adoption of new technologies in hospitals and diagnostic laboratories in the region.

Analysis of Key Players in Global Cardiac Output Monitoring Devices Market

The cardiac output monitoring devices market report includes vital information about the key players operating in the global market. Companies are focusing on strategies such as new product launches, divestiture, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market. GE Healthcare, Getinge AB, Edward Lifesciences Corporation, Baxter International Inc., LiDCO Group plc, ICU Medical, Inc., Deltex Medical Group plc, Uscom, CNSystems Medizintechnik GmbH, and Osypka Medical GmbH are some of the prominent players operating in the global market.

Key Developments in Global Cardiac Output Monitoring Devices Market

  • In November 2021, Philips announced the acquisition of Cardiologs, a France-based medical technology company. The acquisition is expected to strengthen Philips' existing cardiac diagnostics and monitoring portfolio with Cardiologs' innovative software technology, electrocardiogram (ECG) analysis, and reporting services.
  • In November 2021, GE Healthcare announced the launch of a modular, scalable CT platform. The Revolution Apex platform is the first computed tomography (CT) platform with built-in scalability for onsite CT detector upgrades from 40 mm to 80 mm or 160 mm detector coverage without having to replace the gantry. The new Revolution Apex platform has the quickest gantry speed in the world, with 0.23 seconds per rotation and 19.5-millisecond effective temporal resolution to freeze cardiac action.
  • In July 2020, Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) had approved its next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices
  • In 2019, ZOLL Medical, an Asahi Kasei Group Company, acquired Cardiac Science, a leading provider of automated external defibrillators (AEDs), related services, and accessories. The acquisition strengthened ZOLL Medical’s position in the AED segment.
  • In 2018, BIOTRONIK became the exclusive U.S. distributor for InfoBionic’s MoMe Kardia external cardiac diagnostic monitor. This helped the company expand its product portfolio of cardiovascular solutions to support physicians in providing the best care as fast and efficiently as possible.

Each of these players has been profiled in the cardiac output monitoring devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Cardiac Output Monitoring Devices Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 1.14 Bn

Market Forecast Value in 2031

More than US$ 1.77 Bn

Compound Annual Growth Rate (CAGR)

4.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis/ranking by company (2021)
  • Company profiles section includes overview, product portfolio, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Technology
    • Pulmonary Artery Catheter
    • Thermodilution Pulse Contour Analysis Technique
    • Lithium Dilution Technique
    • Arterial Waveform Analysis Technique
    • Doppler
    • Transthoracic Impedance & Bioreactance Analysis
  • Product
    • Consumables & Accessories
    • Devices
  • Type
    • Invasive
    • Non-invasive
  • End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • GE Healthcare
  • Getinge AB
  • Edward Lifesciences Corporation
  • Baxter International, Inc.
  • LiDCO Group plc
  • ICU Medical, Inc.
  • Deltex Medical Group plc
  • Uscom
  • CNSystems Medizintechnik GmbH

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global cardiac output monitoring devices market in 2021?

The global cardiac output monitoring devices market was valued at US$ 1.14 Bn in 2021.

How big will be the global cardiac output monitoring devices market by 2031?

The global market is projected to reach more than US$ 1.77 Bn by 2031.

What will be the CAGR of the global cardiac output monitoring devices market during the forecast period (2022–2031)?

The global cardiac output monitoring devices market is anticipated to grow at a CAGR of 4.5% from 2022 to 2031.

Which are the prominent trends that affect market growth?

Rise in prevalence of cardiovascular diseases and increase in number of surgeries.

What was the market share of the leading segment of the global cardiac output monitoring devices market?

The consumables & accessories segment held the largest share of the global market in terms of revenue in 2021.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global cardiac output monitoring devices market during the forecast period.

Who are the prominent players in the global cardiac output monitoring devices market?

GE Healthcare, Getinge AB, Edward Lifesciences Corporation, Baxter International, Inc., LiDCO Group plc, ICU Medical, Inc., Deltex Medical Group plc, Uscom, CNSystems Medizintechnik GmbH, and Osypka Medical GmbH

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiac-Output Monitoring Devices  Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Cardiac-Output Monitoring Devices  Market Analysis and Forecast, 2022–2031

5. Market Outlook

    5.1. Regulatory Scenario, by Region/globally

6. Global Cardiac-Output Monitoring Devices  Market Analysis and Forecast, by Technology

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Technology, 2022–2031

        6.3.1. Pulmonary Artery Catheter

        6.3.2. Thermodilution Pulse Contour Analysis Technique

        6.3.3. Lithium Dilution Technique

        6.3.4. Arterial Waveform Analysis Techniques

        6.3.5. Doppler

        6.3.6. Transthoracic Impedance & Bioreactance Analysis

        6.3.7. Others

    6.4. Market Attractiveness Analysis, by Technology

7. Global Cardiac-Output Monitoring Devices Market Analysis and Forecast, by Product

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Product, 2022–2031

        7.3.1. Consumables & Accessories

        7.3.2. Devices

    7.4. Market Attractiveness Analysis, by Product

8. Global Cardiac-Output Monitoring Devices Market Analysis and Forecast, by Type

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Type, 2022–2031

        8.3.1. Invasive

        8.3.2. Non-invasive

    8.4. Market Attractiveness Analysis, by Type

9. Global Cardiac-Output Monitoring Devices Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2022–2031

        9.3.1. Hospitals

        9.3.2. Ambulatory Surgical Centers

        9.3.3. Others

    9.4. Market Attractiveness Analysis, by End-user

10. Global Cardiac-Output Monitoring Devices Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Region

11. North America Cardiac-Output Monitoring Devices Market Analysis and Forecast

    11.1. Introduction

    11.2. Market Value Forecast, by Technology, 2022–2031

        11.2.1. Pulmonary Artery Catheter

        11.2.2. Thermodilution Pulse Contour Analysis Technique

        11.2.3. Lithium Dilution Technique

        11.2.4. Arterial Waveform Analysis Techniques

        11.2.5. Doppler

        11.2.6. Transthoracic Impedance & Bioreactance Analysis

        11.2.7. Others

    11.3. Market Value Forecast, by Product, 2022–2031

        11.3.1. Consumables & Accessories

        11.3.2. Devices

    11.4. Market Value Forecast, by Type, 2022–2031

        11.4.1. Invasive

        11.4.2. Non-invasive

    11.5. Market Value Forecast, by End-user, 2022–2031

        11.5.1. Hospitals

        11.5.2. Ambulatory Surgical Centers

        11.5.3. Others

    11.6. Market Value Forecast, by Country, 2022–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Technology

        11.7.2. By Product

        11.7.3. By Type

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Cardiac-Output Monitoring Devices Market Analysis and Forecast

    12.1. Introduction

    12.2. Market Value Forecast, by Technology, 2022–2031

        12.2.1. Pulmonary Artery Catheter

        12.2.2. Thermodilution Pulse Contour Analysis Technique

        12.2.3. Lithium Dilution Technique

        12.2.4. Arterial Waveform Analysis Techniques

        12.2.5. Doppler

        12.2.6. Transthoracic Impedance & Bioreactance Analysis

        12.2.7. Others

    12.3. Market Value Forecast, by Product, 2022–2031

        12.3.1. Consumables & Accessories

        12.3.2. Devices

    12.4. Market Value Forecast, by Type, 2022–2031

        12.4.1. Invasive

        12.4.2. Non-invasive

    12.5. Market Value Forecast, by End-user, 2022–2031

        12.5.1. Hospitals

        12.5.2. Ambulatory Surgical Centers

        12.5.3. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2022–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Technology

        12.7.2. By Product

        12.7.3. By Type

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Cardiac-Output Monitoring Devices Market Analysis and Forecast

    13.1. Introduction

    13.2. Market Value Forecast, by Technology, 2022–2031

        13.2.1. Pulmonary Artery Catheter

        13.2.2. Thermodilution Pulse Contour Analysis Technique

        13.2.3. Lithium Dilution Technique

        13.2.4. Arterial Waveform Analysis Techniques

        13.2.5. Doppler

        13.2.6. Transthoracic Impedance & Bioreactance Analysis

        13.2.7. Others

    13.3. Market Value Forecast, by Product, 2022–2031

        13.3.1. Consumables & Accessories

        13.3.2. Devices

    13.4. Market Value Forecast, by Type, 2022–2031

        13.4.1. Invasive

        13.4.2. Non-invasive

    13.5. Market Value Forecast, by End-user, 2022–2031

        13.5.1. Hospitals

        13.5.2. Ambulatory Surgical Centers

        13.5.3. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2022–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Technology

        13.7.2. By Product

        13.7.3. By Type

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Cardiac-Output Monitoring Devices Market Analysis and Forecast

    14.1. Introduction

    14.2. Market Value Forecast, by Technology, 2022–2031

        14.2.1. Pulmonary Artery Catheter

        14.2.2. Thermodilution Pulse Contour Analysis Technique

        14.2.3. Lithium Dilution Technique

        14.2.4. Arterial Waveform Analysis Techniques

        14.2.5. Doppler

        14.2.6. Transthoracic Impedance & Bioreactance Analysis

        14.2.7. Others

    14.3. Market Value Forecast, by Product, 2022–2031

        14.3.1. Consumables & Accessories

        14.3.2. Devices

    14.4. Market Value Forecast, by Type, 2022–2031

        14.4.1. Invasive

        14.4.2. Non-invasive

    14.5. Market Value Forecast, by End-user, 2022–2031

        14.5.1. Hospitals

        14.5.2. Ambulatory Surgical Centers

        14.5.3. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2022–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Technology

        14.7.2. By Product

        14.7.3. By Type

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East & Africa Cardiac-Output Monitoring Devices Market Analysis and Forecast

    15.1. Introduction

    15.2. Market Value Forecast, by Technology, 2022–2031

        15.2.1. Pulmonary Artery Catheter

        15.2.2. Thermodilution Pulse Contour Analysis Technique

        15.2.3. Lithium Dilution Technique

        15.2.4. Arterial Waveform Analysis Techniques

        15.2.5. Doppler

        15.2.6. Transthoracic Impedance & Bioreactance Analysis

        15.2.7. Others

    15.3. Market Value Forecast, by Product, 2022–2031

        15.3.1. Consumables & Accessories

        15.3.2. Devices

    15.4. Market Value Forecast, by Type, 2022–2031

        15.4.1. Invasive

        15.4.2. Non-invasive

    15.5. Market Value Forecast, by End-user, 2022–2031

        15.5.1. Hospitals

        15.5.2. Ambulatory Surgical Centers

        15.5.3. Others

    15.6. Market Value Forecast, by Country/Sub-region, 2022–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Technology

        15.7.2. By Product

        15.7.3. By Type

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Company Profiles

    16.3. Company Profiles

        16.3.1. GE Healthcare

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. SWOT Analysis

            16.3.1.4. Strategic Overview

        16.3.2. Getinge AB

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. Financial Overview

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. Edward Lifesciences Corporation

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. SWOT Analysis

            16.3.3.4. Strategic Overview

        16.3.4. Baxter International, Inc.

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. Financial Overview

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. LiDCO Group plc

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. Financial Overview

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. ICU Medical, Inc.

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. SWOT Analysis

            16.3.6.4. Strategic Overview

        16.3.7. Deltex Medical Group plc

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. Financial Overview

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. Uscom

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. Financial Overview

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. CNSystems Medizintechnik GmbH.

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. SWOT Analysis

            16.3.9.4. Strategic Overview

        16.3.10. Osypka Medical GmbH

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Product Portfolio

            16.3.10.3. SWOT Analysis

            16.3.10.4. Strategic Overview

List of Tables

Table 1: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Technology, 2022–2031

Table 2: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2022–2031

Table 3: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2022–2031

Table 4: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2022–2031

Table 5: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2022–2031

Table 6: North America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2022–2031

Table 7: North America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Technology, 2022–2031

Table 8: North America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2022–2031

Table 9: North America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2022–2031

Table 10: North America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2022–2031

Table 11: Europe Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 12: Europe Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Technology, 2022–2031

Table 13: Europe Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2022–2031

Table 14: Europe Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2022–2031

Table 15: Europe Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2022–2031

Table 16: Asia Pacific Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 17: Asia Pacific Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Technology, 2022–2031

Table 18: Asia Pacific Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2022–2031

Table 19: Asia Pacific Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2022–2031

Table 20: Asia Pacific Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2022–2031

Table 21: Latin America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 22: Latin America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Technology, 2022–2031

Table 23: Latin America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2022–2031

Table 24: Latin America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2022–2031

Table 25: Latin America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2022–2031

Table 26: Middle East & Africa Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 27: Middle East & Africa Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Technology, 2022–2031

Table 28: Middle East & Africa Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2022–2031

Table 29: Middle East & Africa Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2022–2031

Table 30: Middle East & Africa Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2022–2031

List of Figures

Figure 01: Global Cardiac Output Monitoring Devices Market Value (US$ Mn), by Region, 2021 and 2031

Figure 02: Global Cardiac Output Monitoring Devices Market Revenue (US$ Mn), by Type, 2021

Figure 03: Global Cardiac Output Monitoring Devices Market Revenue, by Technology (US$ Mn), 2021

Figure 04: Global Cardiac Output Monitoring Devices Market Revenue (US$ Mn), by End-user, 2021

Figure 05: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast, 2022–2031

Figure 06: Global Cardiac Output Monitoring Devices Market Value Share, by Product, 2021

Figure 07: Global Cardiac Output Monitoring Devices Market Value Share, by Type, 2021

Figure 08: Global Cardiac Output Monitoring Devices Market Value Share, by Technology, 2021

Figure 09: Global Cardiac Output Monitoring Devices Market Value Share, by End-user, 2021

Figure 10: Global Cardiac Output Monitoring Devices Market Value Share Analysis, by Technology, 2021 and 2031

Figure 11: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Pulmonary Artery Catheter, 2022–2031

Figure 12: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Thermodilution Pulse Contour Analysis Technique, 2022–2031

Figure 13: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Lithium Dilution Technique, 2022–2031

Figure 14: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Arterial Waveform Analysis Techniques, 2022–2031

Figure 15: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Doppler, 2022–2031

Figure 16: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Transthoracic Impedance & Bioreactance Analysis, 2022–2031

Figure 17: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2022–2031

Figure 18: Global Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Technology, 2022–2031

Figure 19: Global Cardiac Output Monitoring Devices Market Value Share (%), by Product, 2021 and 2031

Figure 20: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Consumables & Accessories, 2022–2031

Figure 21: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Devices, 2022–2031

Figure 22: Global Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Product, 2022–2031

Figure 23: Global Cardiac Output Monitoring Devices Market Value Share (%), by Type, 2021 and 2031

Figure 24: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Invasive, 2022–2031

Figure 25: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Non-invasive, 2022–2031

Figure 26: Global Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 27: Global Cardiac Output Monitoring Devices Market Value Share (%), by End-user, 2021 and 2031

Figure 28: Global Cardiac Output Monitoring Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2022–2031

Figure 29: Global Cardiac Output Monitoring Devices Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2022–2031

Figure 30: Global Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2022–2031

Figure 31: Global Cardiac Output Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031

Figure 32: Global Cardiac Output Monitoring Devices Market Value Share Analysis, by Region 2021 and 2031

Figure 33: Global Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Region, 2022–2031

Figure 34: North America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 35: North America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Country, 2021 and 2031

Figure 36: North America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Country, 2022–2031

Figure 37: North America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Technology, 2021 and 2031

Figure 38: North America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Technology, 2022–2031

Figure 39: North America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Product, 2021 and 2031

Figure 40: North America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Product, 2022–2031

Figure 41: North America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Type, 2021 and 2031

Figure 42: North America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 43: North America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by End-user, 2021 and 2031

Figure 44: North America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031

Figure 45: Europe Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 46: Europe Cardiac Output Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 47: Europe Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 48: Europe Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Technology, 2021 and 2031

Figure 49: Europe Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Technology, 2022–2031

Figure 50: Europe Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Product, 2021 and 2031

Figure 51: Europe Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Product, 2022–2031

Figure 52: Europe Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Type, 2021 and 2031

Figure 53: Europe Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 54: Europe Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by End-user, 2021 and 2031

Figure 55: Europe Cardiac Output Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031

Figure 56: Asia Pacific Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 57: Asia Pacific Cardiac Output Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 58: Asia Pacific Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 59: Asia Pacific Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Technology, 2021 and 2031

Figure 60: Asia Pacific Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Technology, 2022–2031

Figure 61: Asia Pacific Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Product, 2021 and 2031

Figure 62: Asia Pacific Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Product, 2022–2031

Figure 63: Asia Pacific Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Type, 2021 and 2031

Figure 64: Asia Pacific Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 65: Asia Pacific Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by End-user, 2021 and 2031

Figure 66: Asia Pacific Cardiac Output Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031

Figure 67: Latin America Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 68: Latin America Cardiac Output Monitoring Devices Market Value Share, by Country/Sub-region, 2021 and 2031

Figure 69: Latin America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 70: Latin America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Technology, 2021 and 2031

Figure 71: Latin America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Technology, 2022–2031

Figure 72: Latin America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Product, 2021 and 2031

Figure 73: Latin America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Product, 2022–2031

Figure 74: Latin America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Type, 2021 and 2031

Figure 75: Latin America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 76: Latin America Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by End-user, 2021 and 2031

Figure 77: Latin America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031

Figure 78: Middle East & Africa Cardiac Output Monitoring Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 79: Middle East & Africa Cardiac Output Monitoring Devices Market Value Share, by Country/Sub-region, 2021 and 2031

Figure 80: Middle East & Africa Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 81: Middle East & Africa Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Technology, 2021 and 2031

Figure 82: Middle East & Africa Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Technology, 2022–2031

Figure 83: Middle East & Africa Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Product, 2021 and 2031

Figure 84: Middle East & Africa America Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Product, 2022–2031

Figure 85: Middle East & Africa Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by Type, 2021 and 2031

Figure 86: Middle East & Africa Cardiac Output Monitoring Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 87: Middle East & Africa Cardiac Output Monitoring Devices Market Value Share (%) Analysis, by End-user, 2021 and 2031

Figure 88: Middle East & Africa Cardiac Output Monitoring Devices Market Attractiveness Analysis, by End-user, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved